Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ipsogen undertakes pilot JAK2 cancer biomarker study with AstraZeneca

Dec. 10, 2007

Inhibiton's ICA-1 compound effective in in vitro testing in various cancer cell lines

Dec. 10, 2007

Nippon Kayaku initiates phase II study of NK-105

Dec. 7, 2007

In vivo antimetastatic activity of novel irreversible uPA inhibitors

Dec. 7, 2007

OncoVista licenses OSI-7904L from OSI Pharmaceuticals

Dec. 7, 2007

AstraZeneca completes enrollment in phase III ZEST study of Zactima for NSCLC

Dec. 5, 2007

FDA accepts Cephalon's NDA for Treanda in chronic lymphocytic leukemia

Dec. 5, 2007

TopoTarget reports positive results from phase II clinical trial of Baceca

Dec. 5, 2007

Novel oncolytic drugs revealed in recent patents

Dec. 5, 2007

European Commission grants orphan medicinal product designation to Revlimid

Dec. 4, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...